Journey Medical (DERM) Change in Account Payables (2020 - 2026)
Journey Medical's (DERM) quarterly Change in Account Payables came in at -$649000.0 in Q1 2026, up 60.57% YoY from -$404182.4 in Q1 2025, and up 76.02% on a QoQ basis from -$2.7 million in Q4 2025.
Journey Medical (DERM) Change in Account Payables (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Change in Account Payables data on file, last reported at -$649000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 60.57% year-over-year to -$649000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.2 million (down 560.49% YoY) and the FY2025 annual result came in at -$7.2 million, down 242.97% from the prior year.
- Change in Account Payables climbed to -$649000.0 in Q1 2026, from -$2.7 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $7.1 million in Q1 2023 to a low of -$11.9 million in Q2 2023.
- A 5-year average of -$825000.0 and a median of -$739000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 736.04% — and 2023, when it plunged 511.99%.
- Tracing DERM's Change in Account Payables over 5 years: stood at $2.9 million in 2022, then tumbled by 440.18% to -$10.0 million in 2023, then jumped by 107.1% to $711000.0 in 2024, then sank by 480.59% to -$2.7 million in 2025, then soared by 76.02% to -$649000.0 in 2026.
- The last three Change in Account Payables figures came in at -$649000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | -153,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -153,000.00 |
| Jun 30, 2026 | -153,000.00 |
| Mar 31, 2026 | -649,000.00 |
| Mar 31, 2026 | -649,000.00 |
| Dec 31, 2025 | -2.71 Mn |
| Dec 31, 2025 | -2.71 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.65 Mn |
| Dec 31, 2024 | 711,000.00 |
| Dec 31, 2024 | 711,000.00 |
| Sep 30, 2024 | 735,000.00 |
| Sep 30, 2024 | 735,000.00 |
| Jun 30, 2024 | -739,000.00 |
| Jun 30, 2024 | -739,000.00 |
| Mar 31, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.81 Mn |